Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 19 entries
Sorted by: Best Match Show Resources per page
Extracellular Vesicles and Citrullinated Histone H3 in Coronavirus Disease 2019 Patients.

Thrombosis and haemostasis

Traby L, Kollars M, Kussmann M, Karer M, Šinkovec H, Lobmeyr E, Hermann A, Staudinger T, Schellongowski P, Rössler B, Burgmann H, Kyrle PA, Eichinger S.
PMID: 34077977
Thromb Haemost. 2021 Jun 02; doi: 10.1055/a-1522-4131. Epub 2021 Jun 02.

OBJECTIVES:  Pulmonary thrombus formation is a hallmark of coronavirus disease 2019 (COVID-19). A dysregulated immune response culminating in thromboinflammation has been described, but the pathomechanisms remain unclear.METHODS:  We studied 41 adult COVID-19 patients with positive results on reverse-transcriptase polymerase-chain-reaction...

Cite
Traby L, Kollars M, Kussmann M, et al. Extracellular Vesicles and Citrullinated Histone H3 in Coronavirus Disease 2019 Patients. Thromb Haemost. 2021;doi: 10.1055/a-1522-4131.
Traby, L., Kollars, M., Kussmann, M., Karer, M., Šinkovec, H., Lobmeyr, E., Hermann, A., Staudinger, T., Schellongowski, P., Rössler, B., Burgmann, H., Kyrle, P. A., & Eichinger, S. (2021). Extracellular Vesicles and Citrullinated Histone H3 in Coronavirus Disease 2019 Patients. Thrombosis and haemostasis, . https://doi.org/10.1055/a-1522-4131
Traby, Ludwig, et al. "Extracellular Vesicles and Citrullinated Histone H3 in Coronavirus Disease 2019 Patients." Thrombosis and haemostasis vol. (2021). doi: https://doi.org/10.1055/a-1522-4131
Traby L, Kollars M, Kussmann M, Karer M, Šinkovec H, Lobmeyr E, Hermann A, Staudinger T, Schellongowski P, Rössler B, Burgmann H, Kyrle PA, Eichinger S. Extracellular Vesicles and Citrullinated Histone H3 in Coronavirus Disease 2019 Patients. Thromb Haemost. 2021 Jun 02; doi: 10.1055/a-1522-4131. Epub 2021 Jun 02. PMID: 34077977.
Copy Download .nbib Format: NLM
Duration of invasive mechanical ventilation prior to extracorporeal membrane oxygenation is not associated with survival in acute respiratory distress syndrome caused by coronavirus disease 2019.

Annals of intensive care

Hermann M, Laxar D, Krall C, Hafner C, Herzog O, Kimberger O, Koenig S, Kraft F, Maleczek M, Markstaller K, Robak O, Rössler B, Schaden E, Schellongowski P, Schneeweiss-Gleixner M, Staudinger T, Ullrich R, Wiegele M, Willschke H, Zauner C, Hermann A.
PMID: 35024972
Ann Intensive Care. 2022 Jan 13;12(1):6. doi: 10.1186/s13613-022-00980-3.

BACKGROUND: Duration of invasive mechanical ventilation (IMV) prior to extracorporeal membrane oxygenation (ECMO) affects outcome in acute respiratory distress syndrome (ARDS). In coronavirus disease 2019 (COVID-19) related ARDS, the role of pre-ECMO IMV duration is unclear. This single-centre, retrospective...

Cite
Hermann M, Laxar D, Krall C, et al. Duration of invasive mechanical ventilation prior to extracorporeal membrane oxygenation is not associated with survival in acute respiratory distress syndrome caused by coronavirus disease 2019. Ann Intensive Care. 2022;12(1):6doi: 10.1186/s13613-022-00980-3.
Hermann, M., Laxar, D., Krall, C., Hafner, C., Herzog, O., Kimberger, O., Koenig, S., Kraft, F., Maleczek, M., Markstaller, K., Robak, O., Rössler, B., Schaden, E., Schellongowski, P., Schneeweiss-Gleixner, M., Staudinger, T., Ullrich, R., Wiegele, M., Willschke, H., Zauner, C., & Hermann, A. (2022). Duration of invasive mechanical ventilation prior to extracorporeal membrane oxygenation is not associated with survival in acute respiratory distress syndrome caused by coronavirus disease 2019. Annals of intensive care, 12(1), 6. https://doi.org/10.1186/s13613-022-00980-3
Hermann, Martina, et al. "Duration of invasive mechanical ventilation prior to extracorporeal membrane oxygenation is not associated with survival in acute respiratory distress syndrome caused by coronavirus disease 2019." Annals of intensive care vol. 12,1 (2022): 6. doi: https://doi.org/10.1186/s13613-022-00980-3
Hermann M, Laxar D, Krall C, Hafner C, Herzog O, Kimberger O, Koenig S, Kraft F, Maleczek M, Markstaller K, Robak O, Rössler B, Schaden E, Schellongowski P, Schneeweiss-Gleixner M, Staudinger T, Ullrich R, Wiegele M, Willschke H, Zauner C, Hermann A. Duration of invasive mechanical ventilation prior to extracorporeal membrane oxygenation is not associated with survival in acute respiratory distress syndrome caused by coronavirus disease 2019. Ann Intensive Care. 2022 Jan 13;12(1):6. doi: 10.1186/s13613-022-00980-3. PMID: 35024972; PMCID: PMC8755897.
Copy Download .nbib Format: NLM
Decision support system to evaluate ventilation in the acute respiratory distress syndrome (DeVENT study)-trial protocol.

Trials

Patel B, Mumby S, Johnson N, Falaschetti E, Hansen J, Adcock I, McAuley D, Takata M, Karbing DS, Jabaudon M, Schellengowski P, Rees SE.
PMID: 35039050
Trials. 2022 Jan 17;23(1):47. doi: 10.1186/s13063-021-05967-2.

BACKGROUND: The acute respiratory distress syndrome (ARDS) occurs in response to a variety of insults, and mechanical ventilation is life-saving in this setting, but ventilator-induced lung injury can also contribute to the morbidity and mortality in the condition. The...

Cite
Patel B, Mumby S, Johnson N, et al. Decision support system to evaluate ventilation in the acute respiratory distress syndrome (DeVENT study)-trial protocol. Trials. 2022;23(1):47doi: 10.1186/s13063-021-05967-2.
Patel, B., Mumby, S., Johnson, N., Falaschetti, E., Hansen, J., Adcock, I., McAuley, D., Takata, M., Karbing, D. S., Jabaudon, M., Schellengowski, P., Rees, S. E. (2022). Decision support system to evaluate ventilation in the acute respiratory distress syndrome (DeVENT study)-trial protocol. Trials, 23(1), 47. https://doi.org/10.1186/s13063-021-05967-2
Patel, Brijesh, et al. "Decision support system to evaluate ventilation in the acute respiratory distress syndrome (DeVENT study)-trial protocol." Trials vol. 23,1 (2022): 47. doi: https://doi.org/10.1186/s13063-021-05967-2
Patel B, Mumby S, Johnson N, Falaschetti E, Hansen J, Adcock I, McAuley D, Takata M, Karbing DS, Jabaudon M, Schellengowski P, Rees SE. Decision support system to evaluate ventilation in the acute respiratory distress syndrome (DeVENT study)-trial protocol. Trials. 2022 Jan 17;23(1):47. doi: 10.1186/s13063-021-05967-2. PMID: 35039050.
Copy Download .nbib Format: NLM
Critically ill patients with cancer: chances and limitations of intensive care medicine-a narrative review.

ESMO open

Schellongowski P, Sperr WR, Wohlfarth P, Knoebl P, Rabitsch W, Watzke HH, Staudinger T.
PMID: 27843637
ESMO Open. 2016 Sep 13;1(5):e000018. doi: 10.1136/esmoopen-2015-000018. eCollection 2016.

This narrative review deals with the challenge of defining adequate therapy goals and intensive care unit (ICU) admission criteria for critically ill patients with cancer. Several specific complications of critically ill patients with cancer require close collaborations of intensive...

Cite
Schellongowski P, Sperr WR, Wohlfarth P, et al. Critically ill patients with cancer: chances and limitations of intensive care medicine-a narrative review. ESMO Open. 2016;1(5):e000018doi: 10.1136/esmoopen-2015-000018.
Schellongowski, P., Sperr, W. R., Wohlfarth, P., Knoebl, P., Rabitsch, W., Watzke, H. H., & Staudinger, T. (2016). Critically ill patients with cancer: chances and limitations of intensive care medicine-a narrative review. ESMO open, 1(5), e000018. https://doi.org/10.1136/esmoopen-2015-000018
Schellongowski, Peter, et al. "Critically ill patients with cancer: chances and limitations of intensive care medicine-a narrative review." ESMO open vol. 1,5 (2016): e000018. doi: https://doi.org/10.1136/esmoopen-2015-000018
Schellongowski P, Sperr WR, Wohlfarth P, Knoebl P, Rabitsch W, Watzke HH, Staudinger T. Critically ill patients with cancer: chances and limitations of intensive care medicine-a narrative review. ESMO Open. 2016 Sep 13;1(5):e000018. doi: 10.1136/esmoopen-2015-000018. eCollection 2016. PMID: 27843637; PMCID: PMC5070251.
Copy Download .nbib Format: NLM
Duration of invasive mechanical ventilation prior to extracorporeal membrane oxygenation is not associated with survival in acute respiratory distress syndrome caused by coronavirus disease 2019.

Annals of intensive care

Hermann M, Laxar D, Krall C, Hafner C, Herzog O, Kimberger O, Koenig S, Kraft F, Maleczek M, Markstaller K, Robak O, Rössler B, Schaden E, Schellongowski P, Schneeweiss-Gleixner M, Staudinger T, Ullrich R, Wiegele M, Willschke H, Zauner C, Hermann A.
PMID: 35024972
Ann Intensive Care. 2022 Jan 13;12(1):6. doi: 10.1186/s13613-022-00980-3.

BACKGROUND: Duration of invasive mechanical ventilation (IMV) prior to extracorporeal membrane oxygenation (ECMO) affects outcome in acute respiratory distress syndrome (ARDS). In coronavirus disease 2019 (COVID-19) related ARDS, the role of pre-ECMO IMV duration is unclear. This single-centre, retrospective...

Cite
Hermann M, Laxar D, Krall C, et al. Duration of invasive mechanical ventilation prior to extracorporeal membrane oxygenation is not associated with survival in acute respiratory distress syndrome caused by coronavirus disease 2019. Ann Intensive Care. 2022;12(1):6doi: 10.1186/s13613-022-00980-3.
Hermann, M., Laxar, D., Krall, C., Hafner, C., Herzog, O., Kimberger, O., Koenig, S., Kraft, F., Maleczek, M., Markstaller, K., Robak, O., Rössler, B., Schaden, E., Schellongowski, P., Schneeweiss-Gleixner, M., Staudinger, T., Ullrich, R., Wiegele, M., Willschke, H., Zauner, C., & Hermann, A. (2022). Duration of invasive mechanical ventilation prior to extracorporeal membrane oxygenation is not associated with survival in acute respiratory distress syndrome caused by coronavirus disease 2019. Annals of intensive care, 12(1), 6. https://doi.org/10.1186/s13613-022-00980-3
Hermann, Martina, et al. "Duration of invasive mechanical ventilation prior to extracorporeal membrane oxygenation is not associated with survival in acute respiratory distress syndrome caused by coronavirus disease 2019." Annals of intensive care vol. 12,1 (2022): 6. doi: https://doi.org/10.1186/s13613-022-00980-3
Hermann M, Laxar D, Krall C, Hafner C, Herzog O, Kimberger O, Koenig S, Kraft F, Maleczek M, Markstaller K, Robak O, Rössler B, Schaden E, Schellongowski P, Schneeweiss-Gleixner M, Staudinger T, Ullrich R, Wiegele M, Willschke H, Zauner C, Hermann A. Duration of invasive mechanical ventilation prior to extracorporeal membrane oxygenation is not associated with survival in acute respiratory distress syndrome caused by coronavirus disease 2019. Ann Intensive Care. 2022 Jan 13;12(1):6. doi: 10.1186/s13613-022-00980-3. PMID: 35024972.
Copy Download .nbib Format: NLM
[No title available]

Wiener klinische Wochenschrift. Education

Schellongowski P.
PMID: 32288849
Wien Klin Wochenschr Educ. 2011;6(4):113-128. doi: 10.1007/s11812-011-0009-8. Epub 2011 Nov 23.

No abstract available.

Cite
Schellongowski P. Onkologische Notfälle. . Wien Klin Wochenschr Educ. 2011;6(4):113-128doi: 10.1007/s11812-011-0009-8.
Schellongowski, P. (2011). Onkologische Notfälle. . Wiener klinische Wochenschrift. Education, 6(4), 113-128. https://doi.org/10.1007/s11812-011-0009-8
Schellongowski, Peter. "Onkologische Notfälle." . Wiener klinische Wochenschrift. Education vol. 6,4 (2011): 113-128. doi: https://doi.org/10.1007/s11812-011-0009-8
Schellongowski P. Onkologische Notfälle. . Wien Klin Wochenschr Educ. 2011;6(4):113-128. doi: 10.1007/s11812-011-0009-8. Epub 2011 Nov 23. German. PMID: 32288849; PMCID: PMC7102327.
Copy Download .nbib Format: NLM
Six-Month Outcome of Immunocompromised Patients with Severe Acute Respiratory Distress Syndrome Rescued by Extracorporeal Membrane Oxygenation. An International Multicenter Retrospective Study.

American journal of respiratory and critical care medicine

Schmidt M, Schellongowski P, Patroniti N, Taccone FS, Reis Miranda D, Reuter J, Prodanovic H, Pierrot M, Dorget A, Park S, Balik M, Demoule A, Crippa IA, Mercat A, Wohlfarth P, Sonneville R, Combes A.
PMID: 29298095
Am J Respir Crit Care Med. 2018 May 15;197(10):1297-1307. doi: 10.1164/rccm.201708-1761OC.

No abstract available.

Cite
Schmidt M, Schellongowski P, Patroniti N, et al. Six-Month Outcome of Immunocompromised Patients with Severe Acute Respiratory Distress Syndrome Rescued by Extracorporeal Membrane Oxygenation. An International Multicenter Retrospective Study. Am J Respir Crit Care Med. 2018;197(10):1297-1307doi: 10.1164/rccm.201708-1761OC.
Schmidt, M., Schellongowski, P., Patroniti, N., Taccone, F. S., Reis Miranda, D., Reuter, J., Prodanovic, H., Pierrot, M., Dorget, A., Park, S., Balik, M., Demoule, A., Crippa, I. A., Mercat, A., Wohlfarth, P., Sonneville, R., Combes, A. (2018). Six-Month Outcome of Immunocompromised Patients with Severe Acute Respiratory Distress Syndrome Rescued by Extracorporeal Membrane Oxygenation. An International Multicenter Retrospective Study. American journal of respiratory and critical care medicine, 197(10), 1297-1307. https://doi.org/10.1164/rccm.201708-1761OC
Schmidt, Matthieu, et al. "Six-Month Outcome of Immunocompromised Patients with Severe Acute Respiratory Distress Syndrome Rescued by Extracorporeal Membrane Oxygenation. An International Multicenter Retrospective Study." American journal of respiratory and critical care medicine vol. 197,10 (2018): 1297-1307. doi: https://doi.org/10.1164/rccm.201708-1761OC
Schmidt M, Schellongowski P, Patroniti N, Taccone FS, Reis Miranda D, Reuter J, Prodanovic H, Pierrot M, Dorget A, Park S, Balik M, Demoule A, Crippa IA, Mercat A, Wohlfarth P, Sonneville R, Combes A. Six-Month Outcome of Immunocompromised Patients with Severe Acute Respiratory Distress Syndrome Rescued by Extracorporeal Membrane Oxygenation. An International Multicenter Retrospective Study. Am J Respir Crit Care Med. 2018 May 15;197(10):1297-1307. doi: 10.1164/rccm.201708-1761OC. PMID: 29298095; PMCID: PMC7252852.
Copy Download .nbib Format: NLM
Critical care management of chimeric antigen receptor T-cell therapy recipients.

CA: a cancer journal for clinicians

Shimabukuro-Vornhagen A, Böll B, Schellongowski P, Valade S, Metaxa V, Azoulay E, von Bergwelt-Baildon M.
PMID: 34613616
CA Cancer J Clin. 2021 Oct 06; doi: 10.3322/caac.21702. Epub 2021 Oct 06.

Chimeric antigen receptor (CAR) T-cell therapy is a promising immunotherapeutic treatment concept that is changing the treatment approach to hematologic malignancies. The development of CAR T-cell therapy represents a prime example for the successful bench-to-bedside translation of advances in...

Cite
Shimabukuro-Vornhagen A, Böll B, Schellongowski P, et al. Critical care management of chimeric antigen receptor T-cell therapy recipients. CA Cancer J Clin. 2021;doi: 10.3322/caac.21702.
Shimabukuro-Vornhagen, A., Böll, B., Schellongowski, P., Valade, S., Metaxa, V., Azoulay, E., & von Bergwelt-Baildon, M. (2021). Critical care management of chimeric antigen receptor T-cell therapy recipients. CA: a cancer journal for clinicians, . https://doi.org/10.3322/caac.21702
Shimabukuro-Vornhagen, Alexander, et al. "Critical care management of chimeric antigen receptor T-cell therapy recipients." CA: a cancer journal for clinicians vol. (2021). doi: https://doi.org/10.3322/caac.21702
Shimabukuro-Vornhagen A, Böll B, Schellongowski P, Valade S, Metaxa V, Azoulay E, von Bergwelt-Baildon M. Critical care management of chimeric antigen receptor T-cell therapy recipients. CA Cancer J Clin. 2021 Oct 06; doi: 10.3322/caac.21702. Epub 2021 Oct 06. PMID: 34613616.
Copy Download .nbib Format: NLM
Critical care management of chimeric antigen receptor T-cell therapy recipients.

CA: a cancer journal for clinicians

Shimabukuro-Vornhagen A, Böll B, Schellongowski P, Valade S, Metaxa V, Azoulay E, von Bergwelt-Baildon M.
PMID: 34613616
CA Cancer J Clin. 2022 Jan;72(1):78-93. doi: 10.3322/caac.21702. Epub 2021 Oct 06.

Chimeric antigen receptor (CAR) T-cell therapy is a promising immunotherapeutic treatment concept that is changing the treatment approach to hematologic malignancies. The development of CAR T-cell therapy represents a prime example for the successful bench-to-bedside translation of advances in...

Cite
Shimabukuro-Vornhagen A, Böll B, Schellongowski P, et al. Critical care management of chimeric antigen receptor T-cell therapy recipients. CA Cancer J Clin. 2021;72(1):78-93doi: 10.3322/caac.21702.
Shimabukuro-Vornhagen, A., Böll, B., Schellongowski, P., Valade, S., Metaxa, V., Azoulay, E., & von Bergwelt-Baildon, M. (2022). Critical care management of chimeric antigen receptor T-cell therapy recipients. CA: a cancer journal for clinicians, 72(1), 78-93. https://doi.org/10.3322/caac.21702
Shimabukuro-Vornhagen, Alexander, et al. "Critical care management of chimeric antigen receptor T-cell therapy recipients." CA: a cancer journal for clinicians vol. 72,1 (2022): 78-93. doi: https://doi.org/10.3322/caac.21702
Shimabukuro-Vornhagen A, Böll B, Schellongowski P, Valade S, Metaxa V, Azoulay E, von Bergwelt-Baildon M. Critical care management of chimeric antigen receptor T-cell therapy recipients. CA Cancer J Clin. 2022 Jan;72(1):78-93. doi: 10.3322/caac.21702. Epub 2021 Oct 06. PMID: 34613616.
Copy Download .nbib Format: NLM
Extracellular Vesicles and Citrullinated Histone H3 in Coronavirus Disease 2019 Patients.

Thrombosis and haemostasis

Traby L, Kollars M, Kussmann M, Karer M, Šinkovec H, Lobmeyr E, Hermann A, Staudinger T, Schellongowski P, Rössler B, Burgmann H, Kyrle PA, Eichinger S.
PMID: 34077977
Thromb Haemost. 2022 Jan;122(1):113-122. doi: 10.1055/a-1522-4131. Epub 2021 Jun 02.

OBJECTIVES:  Pulmonary thrombus formation is a hallmark of coronavirus disease 2019 (COVID-19). A dysregulated immune response culminating in thromboinflammation has been described, but the pathomechanisms remain unclear.METHODS:  We studied 41 adult COVID-19 patients with positive results on reverse-transcriptase polymerase-chain-reaction...

Cite
Traby L, Kollars M, Kussmann M, et al. Extracellular Vesicles and Citrullinated Histone H3 in Coronavirus Disease 2019 Patients. Thromb Haemost. 2021;122(1):113-122doi: 10.1055/a-1522-4131.
Traby, L., Kollars, M., Kussmann, M., Karer, M., Šinkovec, H., Lobmeyr, E., Hermann, A., Staudinger, T., Schellongowski, P., Rössler, B., Burgmann, H., Kyrle, P. A., & Eichinger, S. (2022). Extracellular Vesicles and Citrullinated Histone H3 in Coronavirus Disease 2019 Patients. Thrombosis and haemostasis, 122(1), 113-122. https://doi.org/10.1055/a-1522-4131
Traby, Ludwig, et al. "Extracellular Vesicles and Citrullinated Histone H3 in Coronavirus Disease 2019 Patients." Thrombosis and haemostasis vol. 122,1 (2022): 113-122. doi: https://doi.org/10.1055/a-1522-4131
Traby L, Kollars M, Kussmann M, Karer M, Šinkovec H, Lobmeyr E, Hermann A, Staudinger T, Schellongowski P, Rössler B, Burgmann H, Kyrle PA, Eichinger S. Extracellular Vesicles and Citrullinated Histone H3 in Coronavirus Disease 2019 Patients. Thromb Haemost. 2022 Jan;122(1):113-122. doi: 10.1055/a-1522-4131. Epub 2021 Jun 02. PMID: 34077977.
Copy Download .nbib Format: NLM
[Recommendations for Extracorporeal Membrane Oxygenation (ECMO) in COVID-19 Patients].

Wiener klinisches Magazin : Beilage zur Wiener klinischen Wochenschrift

Wiedemann D, Bernardi MH, Distelmaier K, Goliasch G, Hengstenberg C, Hermann A, Holzer M, Hoetzenecker K, Klepetko W, Lang G, Lassnigg A, Laufer G, Magnet IAM, Markstaller K, Röggla M, Rössler B, Schellongowski P, Simon P, Tschernko E, Ullrich R, Zimpfer D, Staudinger T.
PMID: 32837601
Wien Klin Mag. 2020 Jun 10;1-6. doi: 10.1007/s00740-020-00349-x. Epub 2020 Jun 10.

The pandemic from the SARS-CoV‑2 Virus is currently challenging health care systems all over the world. Maintaining appropriate staffing and resources in healthcare facilities is essential to guarantee a safe work environment for healthcare personnel and safe patient care....

Cite
Wiedemann D, Bernardi MH, Distelmaier K, et al. Empfehlungen für ECMO bei COVID-19-Patienten: Consensus Paper zur Extrakorporalen Membranoxygenierung der Medizinischen Universität Wien. [Recommendations for Extracorporeal Membrane Oxygenation (ECMO) in COVID-19 Patients]. Wien Klin Mag. 2020;1-6doi: 10.1007/s00740-020-00349-x.
Wiedemann, D., Bernardi, M. H., Distelmaier, K., Goliasch, G., Hengstenberg, C., Hermann, A., Holzer, M., Hoetzenecker, K., Klepetko, W., Lang, G., Lassnigg, A., Laufer, G., Magnet, I. A. M., Markstaller, K., Röggla, M., Rössler, B., Schellongowski, P., Simon, P., Tschernko, E., Ullrich, R., Zimpfer, D., Staudinger, T. (2020). Empfehlungen für ECMO bei COVID-19-Patienten: Consensus Paper zur Extrakorporalen Membranoxygenierung der Medizinischen Universität Wien. [Recommendations for Extracorporeal Membrane Oxygenation (ECMO) in COVID-19 Patients]. Wiener klinisches Magazin : Beilage zur Wiener klinischen Wochenschrift, 1-6. https://doi.org/10.1007/s00740-020-00349-x
Wiedemann, Dominik, et al. "Empfehlungen für ECMO bei COVID-19-Patienten: Consensus Paper zur Extrakorporalen Membranoxygenierung der Medizinischen Universität Wien." [Recommendations for Extracorporeal Membrane Oxygenation (ECMO) in COVID-19 Patients]. Wiener klinisches Magazin : Beilage zur Wiener klinischen Wochenschrift vol. (2020): 1-6. doi: https://doi.org/10.1007/s00740-020-00349-x
Wiedemann D, Bernardi MH, Distelmaier K, Goliasch G, Hengstenberg C, Hermann A, Holzer M, Hoetzenecker K, Klepetko W, Lang G, Lassnigg A, Laufer G, Magnet IAM, Markstaller K, Röggla M, Rössler B, Schellongowski P, Simon P, Tschernko E, Ullrich R, Zimpfer D, Staudinger T. Empfehlungen für ECMO bei COVID-19-Patienten: Consensus Paper zur Extrakorporalen Membranoxygenierung der Medizinischen Universität Wien. [Recommendations for Extracorporeal Membrane Oxygenation (ECMO) in COVID-19 Patients]. Wien Klin Mag. 2020 Jun 10;1-6. doi: 10.1007/s00740-020-00349-x. Epub 2020 Jun 10. German. PMID: 32837601; PMCID: PMC7286215.
Copy Download .nbib Format: NLM
[No title available]

Wiener klinisches Magazin : Beilage zur Wiener klinischen Wochenschrift

Schellongowski P, Staudinger T.
PMID: 32288862
Wien Klin Mag. 2012;15(2):24-27. doi: 10.1007/s00740-012-0455-7. Epub 2012 Oct 05.

No abstract available.

Cite
Schellongowski P, Staudinger T. Hämato-onkologische Intensivpatienten: Gefordert: Spezifisches Wissen der Intensivmediziner und Zusammenarbeit mit Onkologen. . Wien Klin Mag. 2012;15(2):24-27doi: 10.1007/s00740-012-0455-7.
Schellongowski, P., & Staudinger, T. (2012). Hämato-onkologische Intensivpatienten: Gefordert: Spezifisches Wissen der Intensivmediziner und Zusammenarbeit mit Onkologen. . Wiener klinisches Magazin : Beilage zur Wiener klinischen Wochenschrift, 15(2), 24-27. https://doi.org/10.1007/s00740-012-0455-7
Schellongowski, Peter, and Staudinger, Thomas. "Hämato-onkologische Intensivpatienten: Gefordert: Spezifisches Wissen der Intensivmediziner und Zusammenarbeit mit Onkologen." . Wiener klinisches Magazin : Beilage zur Wiener klinischen Wochenschrift vol. 15,2 (2012): 24-27. doi: https://doi.org/10.1007/s00740-012-0455-7
Schellongowski P, Staudinger T. Hämato-onkologische Intensivpatienten: Gefordert: Spezifisches Wissen der Intensivmediziner und Zusammenarbeit mit Onkologen. . Wien Klin Mag. 2012;15(2):24-27. doi: 10.1007/s00740-012-0455-7. Epub 2012 Oct 05. German. PMID: 32288862; PMCID: PMC7138135.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 19 entries